Learn More About Trodelvy Patient Support Services

2021 Year in Review - Triple-Negative Breast Cancer

Trodelvy (sacituzumab govitecan-hziy) copayment assistance, reimbursement support, and patient assistance programs are available for eligible patients.1 Prior authorizations and appeals must be submitted by the physician’s office.2 Patients with any type of government insurance are not eligible for the Trodelvy Savings Program.2 To be eligible for this program, patients must meet certain criteria. The patient pays no out-of-pocket costs for Trodelvy once enrolled, with a maximum benefit of $25,000 per year.2

The Gilead Patient Assistance Program provides free access to Trodelvy for patients who are uninsured or underinsured.2 Patients must meet specific eligibility requirements to qualify for assistance.2

Patients with Medicare or other government insurance who require copay or coinsurance assistance for Trodelvy may be eligible for assistance from an independent copay assistance foundation.2 Patients can work with case managers to determine their high-level eligibility for Trodelvy coverage through an independent copay assistance foundation.2 Case managers and nurse navigators can provide information on any available foundations if copay assistance is needed. A foundation will determine the patient’s eligibility for copay or coinsurance assistance based on their individual criteria and will contact the patient directly on the application process, fully independent of Gilead and its agents. Gilead and its representatives make no assurances about compensation for any service or material.2

The Trodelvy Savings Program is for commercially or privately insured patients, offering up to $25,000 in savings on out-of-pocket payments for Trodelvy 180-mg single-dose vials. Only the cost of Trodelvy is covered by the program; the patient is responsible for the cost of treatments and office visits.2

Any claims funded, paid, or reimbursed in whole or in part by Medicaid, Medicare, or other federal or state healthcare programs are not supported by this program.2

Trodelvy Access Support case managers can provide information about independent third-party groups that may be able to help with the cost of treatment to patients who are unable to afford their medication (including those with Medicare, Medicaid, or other government-sponsored insurance). Trodelvy coverage, coding, and billing requirements vary by plan and patient.2

Further information can be found at https://trodelvyhcp.com/hcp/mTNBC/access-support or www.needymeds.org/brand-drug/name/Trodelvy.

References

  1. Needymeds.com. Trodelvy. Updated September 2021. www.needymeds.org/brand-drug/name/Trodelvy. Accessed November 15, 2021.
  2. Trodelvyhcp.com. Trodelvy access support. Updated September 2021. https://trodelvyhcp.com/hcp/mTNBC/access-support. Accessed November 15, 2021.

Related Items

Supporting Young Patients With Breast Cancer
By Zeena Nackerdien, PhD
December 2025 Vol 16, No 12
Explore the unique challenges faced by young patients with breast cancer and learn how innovative navigation programs are bridging gaps in care and empowering patients to thrive.
Identification and Treatment of Patients With Hormone Receptor–Positive, HER2-Negative Early Breast Cancer at High Risk of Recurrence: monarchE Study Long-Term Outcomes
Special Issues and Supplements
We are pleased to announce the release of our next issue of Clinical Trials to Clinical Practice. This article provides expert commentary from Joyce A. O’Shaughnessy, MD, on the use of endocrine therapy with or without adjuvant abemaciclib for patients with high-risk, hormone receptor (HR)-positive, HER2-negative early breast cancer.
Navigator Guide: Walking With a Patient Down the Early Breast Cancer Path
Resources
The Navigator Guide: Walking With a Patient Down the Early Breast Cancer Path is a resource that oncology nurses and navigators can use to assist patients and caregivers in the fight against early-stage breast cancer. Oncology nurses and navigators guide patients through their treatment journey from time of diagnosis into survivorship, providing education, resources, and support.
Journal of Oncology Navigation & Survivorship
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country